RANGAP1 and colorectal carcinoma: To investigate the underlying mechanism by which RanGAP1 promotes CRC progression through the MAPK signaling pathway, co-immunoprecipitation followed by protein mass spectrometry (MS) was conducted to identify the proteins that interact with RanGAP1 in CRC cells.